TrialSignal transduction and targeted therapy2025

Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06).

Yi-Ge Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.